[{"StockholdersEquityConverted_0_Q1_USD":10975000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1099000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-405000000.0,"EarningsPerShareDiluted_1_Q1_USD":0.07,"StockholdersEquity_0_Q1_USD":10000000000.0,"NetIncomeLossConverted_1_Q1_USD":84000000.0,"EarningsPerShareBasic_1_Q1_USD":0.07,"RevenuesConverted_1_Q1_USD":3982000000.0,"Assets_0_Q1_USD":49004000000.0,"CommonStockSharesConverted_0_Q1_shares":1208000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1107000000.0,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210428"}]